Good Pharmacovigilance Practices (GVP)

The Fundamentals of Good Pharmacovigilance Practices (GVP)

“The Fundamentals of Good Pharmacovigilance Practices (GVP)” is a basic level course providing the foundation of what pharmacovigilance is and what adverse drug reactions are. The course provides a high-level overview for those just getting started in GVP or those needing a refresher.

CEU Credits: 0.1
Course Code: ELM-920
Duration: 20 mins
Skill Level: Basic
Language: English
Final Exam: Yes
Certification: Yes
Version: V2.1
Effective Date: 02/29/2024

Curriculum for this course

Course Introduction
Goals
Objectives
Knowledge Check
Impacts of Adverse Drug Reaction (ADR)
Classification of Adverse Drug Reaction (ADR) - Frequency
Classification of Adverse Drug Reaction (ADR) - Type
Pharmacovigilance vs ADR
A Global Initative
Types of Reports
Report Validation
Follow Up and Data Management

Summary

Test Your Knowledge

v2.1 Minor update on 1/31/2025 Course template enhanced to provide more specific quiz completion data and a Version History document. Course content has not been changed.
v2.0 Major update on 02/29/2024. This course has been redesigned. The course content, objectives and visual design have been updated to reflect current best practices surrounding The Fundamentals of Good Pharmacovigilance
v1.4 Minor update on 02/16/2024 to improve learning objectives and exam questions
v1.2 Minor update on 04/10/2023 to fix a typo
v1.1 Minor update on 12/08/2022 to fix assessment functionality
v1.0 Course released in 2021

Author

Joginder Mittal

Manager - Quality Compliance Glatt Pharma Engineering

Courses

Browse our extensive catalog of GxP, Corporate Compliance and EH&S training.

Learning Strategy

Boost your organization’s training with LearnGxP’s Learning Strategy Consultants (LSC). They customize learning paths to match your needs, offering ongoing support for lasting success.

Customer Stories

Discover how LearnGxP addresses real challenges, provides effective solutions, and positively impacts our customers’ organizations.